Business News

Vertex Shares Higher On Optimism About CRISPR Partnership

Shares of Vertex Pharmaceuticals are moving higher on news that regulators gave the company the go-ahead to on the review process for gene-editing treatments.

Business News

CRISPR Offers the Potential to Live Forever, But to What End?

Chinese scientists have successfully prolonged the lives of mice by using CRISPR.